These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 19664691)

  • 1. Increasing O-GlcNAc levels: An overview of small-molecule inhibitors of O-GlcNAcase.
    Macauley MS; Vocadlo DJ
    Biochim Biophys Acta; 2010 Feb; 1800(2):107-21. PubMed ID: 19664691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. E. coli sabotages the in vivo production of O-linked β-N-acetylglucosamine-modified proteins.
    Goodwin OY; Thomasson MS; Lin AJ; Sweeney MM; Macnaughtan MA
    J Biotechnol; 2013 Dec; 168(4):315-23. PubMed ID: 24140293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of O-linked N-acetylglucosamine levels on nuclear and cytoplasmic proteins in vivo using the peptide O-GlcNAc-beta-N-acetylglucosaminidase inhibitor O-(2-acetamido-2-deoxy-D-glucopyranosylidene)amino-N-phenylcarbamate.
    Haltiwanger RS; Grove K; Philipsberg GA
    J Biol Chem; 1998 Feb; 273(6):3611-7. PubMed ID: 9452489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a specific inhibitor of nOGA - a caspase-3 cleaved O-GlcNAcase variant during apoptosis.
    Li J; Li Z; Li T; Lin L; Zhang Y; Guo L; Xu Y; Zhao W; Wang P
    Biochemistry (Mosc); 2012 Feb; 77(2):194-200. PubMed ID: 22348480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissecting PUGNAc-mediated inhibition of the pro-survival action of insulin.
    Teo CF; El-Karim EG; Wells L
    Glycobiology; 2016 Nov; 26(11):1198-1208. PubMed ID: 27072814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. O-GLcNAc post-translational modifications regulate the entry of neurons into an axon branching program.
    Francisco H; Kollins K; Varghis N; Vocadlo D; Vosseller K; Gallo G
    Dev Neurobiol; 2009 Feb 1-15; 69(2-3):162-73. PubMed ID: 19086029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Streptozotocin-induced beta-cell death is independent of its inhibition of O-GlcNAcase in pancreatic Min6 cells.
    Gao Y; Parker GJ; Hart GW
    Arch Biochem Biophys; 2000 Nov; 383(2):296-302. PubMed ID: 11185566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ac
    Wang H; Guo J; Wang N; Wang J; Xue Q; Wang J; Liu W; Liu K; Cao X; Zhao W; Xi R; Niu Y; Wang P; Li J
    Bioorg Med Chem Lett; 2019 Mar; 29(6):802-805. PubMed ID: 30713024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of O-GlcNAcase by a gluco-configured nagstatin and a PUGNAc-imidazole hybrid inhibitor.
    Shanmugasundaram B; Debowski AW; Dennis RJ; Davies GJ; Vocadlo DJ; Vasella A
    Chem Commun (Camb); 2006 Nov; (42):4372-4. PubMed ID: 17057847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence of the involvement of O-GlcNAc-modified human RNA polymerase II CTD in transcription in vitro and in vivo.
    Ranuncolo SM; Ghosh S; Hanover JA; Hart GW; Lewis BA
    J Biol Chem; 2012 Jul; 287(28):23549-61. PubMed ID: 22605332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An O-GlcNAcase-specific inhibitor and substrate engineered by the extension of the N-acetyl moiety.
    Kim EJ; Perreira M; Thomas CJ; Hanover JA
    J Am Chem Soc; 2006 Apr; 128(13):4234-5. PubMed ID: 16568991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Caenorhabditis elegans ortholog of a diabetes susceptibility locus: oga-1 (O-GlcNAcase) knockout impacts O-GlcNAc cycling, metabolism, and dauer.
    Forsythe ME; Love DC; Lazarus BD; Kim EJ; Prinz WA; Ashwell G; Krause MW; Hanover JA
    Proc Natl Acad Sci U S A; 2006 Aug; 103(32):11952-7. PubMed ID: 16882729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of O-GlcNAcase in perfused rat hearts by NAG-thiazolines at the time of reperfusion is cardioprotective in an O-GlcNAc-dependent manner.
    Laczy B; Marsh SA; Brocks CA; Wittmann I; Chatham JC
    Am J Physiol Heart Circ Physiol; 2010 Nov; 299(5):H1715-27. PubMed ID: 20833964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological Inhibition of O-GlcNAcase Does Not Increase Sensitivity of Glucocorticoid Receptor-Mediated Transrepression.
    Stivers PJ; Harmonay L; Hicks A; Mehmet H; Morris M; Robinson GM; Strack PR; Savage MJ; Zaller DM; Zwierzynski I; Brandish PE
    PLoS One; 2015; 10(12):e0145151. PubMed ID: 26670328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytosolic O-GlcNAc accumulation is not involved in beta-cell death in HIT-T15 or Min6.
    Okuyama R; Yachi M
    Biochem Biophys Res Commun; 2001 Sep; 287(2):366-71. PubMed ID: 11554736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. O-GlcNAc signaling attenuates ER stress-induced cardiomyocyte death.
    Ngoh GA; Hamid T; Prabhu SD; Jones SP
    Am J Physiol Heart Circ Physiol; 2009 Nov; 297(5):H1711-9. PubMed ID: 19734355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. O-linked beta-N-acetylglucosaminylation in mouse embryonic neural precursor cells.
    Yanagisawa M; Yu RK
    J Neurosci Res; 2009 Dec; 87(16):3535-45. PubMed ID: 19598243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective decrease of membrane-associated PKC-alpha and PKC-epsilon in response to elevated intracellular O-GlcNAc levels in transformed human glial cells.
    Matthews JA; Acevedo-Duncan M; Potter RL
    Biochim Biophys Acta; 2005 Apr; 1743(3):305-15. PubMed ID: 15843043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. O-GlcNAc modification on IRS-1 and Akt2 by PUGNAc inhibits their phosphorylation and induces insulin resistance in rat primary adipocytes.
    Park SY; Ryu J; Lee W
    Exp Mol Med; 2005 Jun; 37(3):220-9. PubMed ID: 16000877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of O-GlcNAcase using a potent and cell-permeable inhibitor does not induce insulin resistance in 3T3-L1 adipocytes.
    Macauley MS; He Y; Gloster TM; Stubbs KA; Davies GJ; Vocadlo DJ
    Chem Biol; 2010 Sep; 17(9):937-48. PubMed ID: 20851343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.